v3.24.2.u1
SHARE-BASED PAYMENTS (Tables)
 6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
The Company’s share-based compensation expense, by type of award, is as follows:
Three Months Ended
June 30,		Six Months Ended
June 30,
2024202320242023
RSUs(1)
$838 $1,162 $1,582 $1,806 
SARs111 304 264 740 
Stock options463 88 911 194 
Total share-based compensation expense(2)
$1,412 $1,554 $2,757 $2,740 
(1)The fair value of the RSUs granted under the Compensation Plan for the six months ended June 30, 2024 and 2023 was estimated at the date of grant using the stated market price on the NYSE American.
(2)Share-based compensation is included in Selling, general and administration in the Condensed Consolidated Statements of Operations and Comprehensive Income.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
A summary of the Company’s unvested RSU activity is as follows:
 Number of SharesWeighted Average Grant Date Fair Value
Unvested, December 31, 2023641,839 $6.57 
Granted375,384 7.47 
Vested(373,067)6.20 
Forfeited— — 
Unvested, June 30, 2024644,156 $7.31 
A summary of the Company’s SARs activity is as follows:
 Number of SharesWeighted Average
Exercise Price		Weighted Average Remaining Contractual Life (Years)Intrinsic Value
Outstanding, December 31, 20231,839,528 $5.01 
Granted— — 
Exercised(250,036)2.92 
Forfeited(3,152)7.36 
Expired(569,595)2.94 
Outstanding, June 30, 20241,016,745 $6.67 2.80$—
Exercisable, June 30, 2024— $— — $—

A summary of the Company’s unvested SARs activity is as follows:

 Number of SharesWeighted Average Grant Date Fair Value
Unvested, December 31, 20231,589,492 $2.89 
Granted— — 
Vested— — 
Expired(569,595)4.51 
Forfeited(3,152)3.45 
Unvested, June 30, 20241,016,745 $3.83 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair value of all stock options, including Performance Based Options, granted under the Compensation Plan for the six months ended June 30, 2024 was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:
Risk-free interest rate4.73 %
Expected life3.08
Expected volatility(1)
69.05 %
Expected dividend yield— %
Weighted average grant date fair value$3.53 
(1)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the stock options.
Schedule of Share-based Compensation, Stock Options, Activity
A summary of all of the Company’s stock option activity, including Performance Based Options, is as follows:
 Range of Exercise PricesNumber of SharesWeighted Average
Exercise Price		Weighted Average Remaining Contractual Life (Years)Intrinsic Value
Outstanding, December 31, 2023
$1.76 - $8.60
523,468 $4.48 
 Granted
5.43 - 8.23
583,546 7.74 
 Exercised
1.76 - 6.47
(46,382)3.37 
 Forfeited
6.12 - 8.23
(19,959)7.40 
 Expired
2.92 - 7.36
(2,291)5.75 
Outstanding, June 30, 2024
$1.76 - $8.60
1,038,382 $6.31 3.19$896 
Exercisable, June 30, 2024
$1.76 - $8.41
402,325 $4.09 1.61$892 
A summary of the Company’s unvested stock option activity is as follows:
 Number of SharesWeighted Average Grant Date Fair Value
Unvested, December 31, 2023169,182 $4.11 
Granted583,546 3.53 
Vested(96,712)4.35 
Forfeited(19,959)3.69 
Unvested, June 30, 2024636,057 $3.56